共聚焦显微镜一站式诊疗对比标准诊疗用于基底细胞癌手术:开放标签、非劣效性、随机对照多中心试验
该开放标签、平行组、非劣效性随机对照多中心试验纳入95例临床疑似基底细胞癌患者,比较反射式共聚焦显微镜(RCM)一站式诊疗(RCM诊断和分型后直接手术切除)与标准诊疗(基于钻取活检组织学诊断和分型后计划切除)的疗效。结论提示该新策略可能适合促进基底细胞癌患者的早期诊断和直接治疗。
要点
- RCM一站式诊疗组切缘无肿瘤比例为100%(40/40),标准诊疗组为94%(31/33)。
- 新策略适用性需考虑RCM可用性、病灶大小和部位、患者偏好及直接手术可行性。
核心结论
- 在临床疑似基底细胞癌患者中,RCM一站式诊疗在手术切除后切缘无肿瘤比例方面非劣效于标准诊疗。
- 所提出的新治疗策略似乎适合促进基底细胞癌患者的早期诊断和直接治疗。
研究设计与样本
- 开放标签、平行组、非劣效性、随机对照多中心试验,在荷兰阿姆斯特丹两个三级转诊中心纳入95例临床疑似基底细胞癌患者。
- 患者随机分配至RCM一站式诊疗组(RCM诊断和分型后直接手术切除)或标准诊疗组(基于钻取活检组织学诊断和分型后计划切除)。
- 主要结局为基底细胞癌手术切除后切缘无肿瘤的患者比例。
主要发现
- 95例患者中,73例(77%)经手术切除标本组织学确认基底细胞癌。
- 一站式诊疗组所有患者(40/40,100%)切缘无肿瘤。
- 标准诊疗组除2例外(31/33,94%)切缘无肿瘤。
临床怎么用
- RCM一站式诊疗可作为临床疑似基底细胞癌患者的一种治疗策略,促进早期诊断和直接治疗。
- 应用时需考虑RCM可用性、病灶大小和部位、患者偏好以及直接手术切除是否可行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Routine punch biopsies are considered to be standard care for diagnosing and subtyping basal cell carcinoma (BCC) when clinically suspected. OBJECTIVES: We assessed the efficacy of a one-stop-shop concept using in vivo reflectance confocal microscopy (RCM) imaging as a diagnostic tool vs. standard care for surgical treatment in patients with clinically suspected BCC. METHODS: In this open-label, parallel-group, noninferiority, randomized controlled multicentre trial we enrolled patients with clinically suspected BCC at two tertiary referral centres in Amsterdam, the Netherlands. Patients were randomly assigned to the RCM one-stop-shop (diagnosing and subtyping using RCM followed by direct surgical excision) or standard care (planned excision based on the histological diagnosis and subtype of a punch biopsy). The primary outcome was the proportion of patients with tumour-free margins after surgical excision of BCC. RESULTS: Of the 95 patients included, 73 (77%) had a BCC histologically confirmed using a surgical excision specimen. All patients (40 of 40, 100%) in the one-stop-shop group had tumour-free margins. In the standard-care group tumour-free margins were found in all but two patients (31 of 33, 94%). The difference in the proportion of patients with tumour-free margins after BCC excision between the one-stop-shop group and the standard-care group was -0·06 (90% confidence interval -0·17-0·01), establishing noninferiority. CONCLUSIONS: The proposed new treatment strategy seems suitable in facilitating early diagnosis and direct treatment for patients with BCC, depending on factors such as availability of RCM, size and site of the lesion, patient preference and whether direct surgical excision is feasible.
引用
- Kadouch DJ, Elshot YS, Zupan-Kajcovski B, et al. One-stop-shop with confocal microscopy imaging vs. standard care for surgical treatment of basal cell carcinoma: an open-label, noninferiority, randomized controlled multicentre trial. Br J Dermatol. 2017. PMID: 28391599. doi:10.1111/bjd.15559
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。